Abstract:Background: The optimal lymphadenectomy approach for solid-dominant stage I non-small-cell lung cancer (NSCLC) is controversial. The present study aimed to compare the survival outcomes following lobectomy with different varieties of lymphadenectomy in patients with solid-dominant stage I NSCLC.Methods: Patients diagnosed with solid-dominant stage I NSCLC from 2008 to 2015 were included and grouped according to the mode of lymphadenectomy. Disease-free survival (DFS) and overall survival (OS) were compared, and univariate survival analysis was performed among groups. Cox analysis was used to identify independent prognostic factors. Nomograms for survival prediction based on lymphadenectomy mode were constructed and internally calibrated. Propensity score matching (PSM) was used to balance the potential confounders. After PSM, subgroup comparisons between bilateral mediastinal lymphadenectomy (BML), systematic nodal dissection (SND), lobe-specific lymph node dissection (LSND) and systematic nodal sampling (SNS) were conducted.Findings: In total, 983 patients were included. The 5-year OS rates were 98.2%, 86.9%, 86.4%, 82.8% (p=0.006), and the 5-year DFS rates were 87.1%, 76.4%, 69.5%, 70.9% (p=0.008) in the BML, SND, LSND and SNS groups, respectively. Compared with SNS, BML was independently associated with better OS and DFS. After PSM, patients who underwent BML showed better OS (HR, 0.358; 95% CI, 0.127-1.008; p=0.052) and DFS (HR, 0.563; 95% CI 0.295-1.074; p=0.081) than those who underwent SND, with marginal significance. Compared with L-SND and SNS, BML was associated with significantly improved OS (HR, 0.343; 95% CI 0.123-0.958; p=0.041 and HR, 0.250; 95% CI 0.088-0.709; p=0.009, respectively) and DFS (HR, 0.474; 95% CI 0.258-0.868; p=0.016 and HR, 0.467; 95% CI 0.232-0.938; p=0.032, respectively). Subgroup analyses demonstrated that for male patients and those whose tumors were larger or more advanced, BML was associated with significantly better OS and DFS than other types of lymphadenectomy.Interpretation: In patients with solid-dominant stage I NSCLC, BML might be associated with better survival and is recommended for these patients, especially those with large tumors.Funding Information: This study was supported by the grant from the National Key R&D Program of China (2016YFC0905400).Declaration of Interests: The authors declare no conflicts of interest in this work.Ethics Approval Statement: This study was approved by the Institutional Review Board of Sun Yat-sen University Cancer Center (B2018-011) and the Medical Ethics Committee of the First Affiliated Hospital, School of Medicine, Zhejiang University (2013-255-1).

Solid Subtype Predicts Early Bone Metastases in Sensitive EGFR-mutated Lung Adenocarcinoma Patients after Surgery.

The Prognostic and Predictive Value of Solid Subtype in Invasive Lung Adenocarcinoma

Bilateral Mediastinal Lymphadenectomy is Associated with Potential Survival Advantages in Patients with Solid-Dominant Stage I Non-Small-Cell Lung Cancer Who Underwent Anatomic Lung Resection

Lung Adenocarcinomas Manifesting As Radiological Part-Solid Nodules Define a Special Clinical Subtype.

Prognosis of EGFR-mutant Advanced Lung Adenocarcinoma Patients with Different Intrathoracic Metastatic Patterns

Solid Predominant Histologic Subtype and Early Recurrence Predict Poor Postrecurrence Survival in Patients with Stage I Lung Adenocarcinoma

Metabolic phenotypes, serum tumor markers, and histopathological subtypes in predicting bone metastasis: analysis of 695 patients with lung cancer in China

Subsolid Lung Adenocarcinomas: Radiological, Clinical and Pathological Features and Outcomes.

Lung adenocarcinoma: selection of surgical approaches in solid adenocarcinoma from the viewpoint of clinicopathologic features and tumor microenvironmental heterogeneity

Impact of Solid Minor Histologic Subtype in Postsurgical Prognosis of Stage I Lung Adenocarcinoma.

The prognostic impact of epidermal growth factor receptor mutation in clinical stage I lung adenocarcinoma

MA12.10 Histological Subtyping of Matched Primary and Metastases Sites in Lung Adenocarcinoma: Significance of Solid Predominance

Genetic-pathological prediction for timing and site-specific recurrence pattern in resected lung adenocarcinoma

Clinicopathologic Features and Prognostic Value of Epidermal Growth Factor Receptor Mutation in Patients with Pt1a and Pt1b Invasive Lung Adenocarcinoma after Surgical Resection

Postoperative recurrence of clinical early-stage non-small cell lung cancers: a comparison between solid and subsolid nodules

Prognostic Value of Epidermal Growth Factor Receptor Gene Mutation in Resected Lung Adenocarcinoma

Distinct Prognostic Factors in Patients with Stage I Non–Small Cell Lung Cancer with Radiologic Part-Solid or Solid Lesions

High-risk-pattern Lung Adenocarcinoma with Epidermal Growth Factor Receptor Mutation is Associated with Distant Metastasis Risk and May Benefit from Adjuvant Targeted Therapy

Correlation of Survival and EGFR Mutation with Predominant Histologic Subtype According to the New Lung Adenocarcinoma Classification in Stage IB Patients

Pan-Driver-Negatives Versus Epidermal Growth Factor Receptor Mutants for C-Stage IA Lung Adenocarcinoma with Ground-Glass Opacity

Inferior outcome of bone metastasis in non-small-cell-lung-cancer patients treated with epidermal growth factor receptor inhibitors